ALX3 and skin squamous cell carcinoma: To conclude, this study demonstrated that ALX3 recruits KDM2B to promote expression of CDC25A through the demethylation of H3K4me3 in the promoter region of CDC25A, which consequently activates the PI3K/Akt pathway and promotes progression of CSCC.